Thromb Haemost 2007; 97(05): 866-868
DOI: 10.1160/TH06-04-0195
Letters to the Editor
Schattauer GmbH

Any effect of CYP2C9 variants on warfarin clearance in Chinese patients?

Joyce H. S. You
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Zhong Zuo
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Cindy M. Y. Lo
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Limin Zhou
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Hillary H. W. Yiu
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Carrie T. S. Chau
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Kai Chow Choi
2  Centre for Epidemiology and Biostatistics, The Chinese University of Hong Kong
,
David K. M. Choi
1  School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Raymond S. M. Wong
3  Division of Haematology, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong; Hong Kong
,
Gregory Cheng
3  Division of Haematology, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong; Hong Kong
› Author Affiliations
Financial support: The study was supported by a Direct Grant for Research (project code: 2041154) from The Chinese University of Hong Kong.
Further Information

Publication History

Received 09 April 2006

Accepted after resubmission 21 February 2007

Publication Date:
24 November 2017 (online)